Detalhe da pesquisa
1.
Prevalence of vaccine-derived hepatitis B surface antibodies in children and adolescents in Germany: results from a population-based survey, 2014-2017.
BMC Infect Dis
; 24(1): 318, 2024 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38491438
2.
Prevalence of Chlamydia trachomatis in the general population in Germany - a triangulation of data from two population-based health surveys and a laboratory sentinel system.
BMC Public Health
; 22(1): 1107, 2022 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35659641
3.
[Epidemiology of viral hepatitis A to E in Germany]. / Epidemiologie der Virushepatitiden A bis E in Deutschland.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
; 65(2): 149-158, 2022 Feb.
Artigo
em Alemão
| MEDLINE | ID: mdl-35029725
4.
[Hepatitis B virus infection and vaccine-induced immunity: the role of sociodemographic determinants : Results of the study "German Health Interview and Examination Survey for Adults" (DEGS1, 2008-2011)]. / Hepatitis-B-Virus-Infektionen und impfinduzierte Immunität: die Rolle von soziodemografischen Determinanten : Ergebnisse der "Studie zur Gesundheit Erwachsener in Deutschland" (DEGS1, 20082011).
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
; 65(2): 159-169, 2022 Feb.
Artigo
em Alemão
| MEDLINE | ID: mdl-34958395
5.
Hepatitis B vaccination coverage in Germany: systematic review.
BMC Infect Dis
; 21(1): 817, 2021 Aug 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34391406
6.
Markedly decreasing azithromycin susceptibility of Neisseria gonorrhoeae, Germany, 2014 to 2021.
Euro Surveill
; 26(31)2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34355690
7.
[How to assess the elimination of viral hepatitis B, C, and D in Germany? Outcomes of an interdisciplinary workshop]. / Wie lässt sich die Eliminierung von Hepatitis B, C und D in Deutschland messen? Ergebnisse eines interdisziplinären Arbeitstreffens.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
; 64(1): 77-90, 2021 Jan.
Artigo
em Alemão
| MEDLINE | ID: mdl-33326051
8.
External quality assessment (EQA) of Neisseria gonorrhoeae antimicrobial susceptibility testing in primary laboratories in Germany.
BMC Infect Dis
; 20(1): 514, 2020 Jul 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32677988
9.
Molecular epidemiological typing of Neisseria gonorrhoeae isolates identifies a novel association between genogroup G10557 (G7072) and decreased susceptibility to cefixime, Germany, 2014 to 2017.
Euro Surveill
; 25(41)2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33063655
10.
[How well is the screening of pregnant women for HIV, syphilis, and hepatitis B implemented in Germany? An analysis based on routine data]. / Gelingt das Screening von Schwangeren auf HIV, Syphilis und Hepatitis B in Deutschland? Eine Analyse auf Basis von Routinedaten.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
; 63(9): 1143-1150, 2020 Sep.
Artigo
em Alemão
| MEDLINE | ID: mdl-32840637
11.
Comment on "Population-based screening works: Effect of integrating screening for hepatitis B and C into the general health check-up in Germany".
J Hepatol
; 2024 Feb 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38403028
12.
Not again! Effect of previous test results, age group and reason for testing on (re-)infection with Chlamydia trachomatis in Germany.
BMC Infect Dis
; 18(1): 424, 2018 Aug 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-30144825
13.
Antimicrobial resistance of Neisseria gonorrhoeae in Germany: low levels of cephalosporin resistance, but high azithromycin resistance.
BMC Infect Dis
; 18(1): 44, 2018 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-29343220
14.
Prävention der nosokomialen Übertragung von Hepatitis-B-Virus (HBV) und Hepatitis-C-Virus (HCV) durch im Gesundheitswesen Tätige : Empfehlungen der Deutschen Vereinigung zur Bekämpfung der Viruskrankheiten (DVV) e. V.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
; 63(2): 218-225, 2020 Feb.
Artigo
em Alemão
| MEDLINE | ID: mdl-32002594
15.
Prevalence of hepatitis B virus infection among general population of Armenia in 2021 and factors associated with it: a cross-sectional study.
BMJ Open
; 14(2): e080281, 2024 02 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38326250
16.
Evaluating the hepatitis B vaccination impact in the Republic of Moldova: A nationwide representative serosurvey of children born in 2013.
IJID Reg
; 10: 60-66, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38384785
17.
Prevalence of chronic HCV infection in EU/EEA countries in 2019 using multiparameter evidence synthesis.
Lancet Reg Health Eur
; 36: 100792, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38188273
18.
Additional challenges in reaching hepatitis C elimination goals in Germany due to the COVID-19 pandemic - descriptive analysis of drug prescription data from January 2018 to June 2021.
Front Public Health
; 11: 1149694, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37325322
19.
Corrigendum: Increasing Number of Individuals Receiving Hepatitis B nucleos(t)ide Analogs Therapy in Germany, 2008-2019.
Front Public Health
; 10: 860836, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35359795
20.
Increasing Number of Individuals Receiving Hepatitis B nucleos(t)ide Analogs Therapy in Germany, 2008-2019.
Front Public Health
; 9: 667253, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34095070